Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Other Working Capital Changes (2020 - 2025)

NeuroPace has reported Other Working Capital Changes over the past 6 years, most recently at $437000.0 for Q4 2025.

  • Quarterly results put Other Working Capital Changes at $437000.0 for Q4 2025, up 1116.28% from a year ago — trailing twelve months through Dec 2025 was -$943000.0 (down 145.57% YoY), and the annual figure for FY2025 was -$943000.0, down 145.57%.
  • Other Working Capital Changes for Q4 2025 was $437000.0 at NeuroPace, up from -$1.5 million in the prior quarter.
  • Over the last five years, Other Working Capital Changes for NPCE hit a ceiling of $2.8 million in Q2 2021 and a floor of -$3.2 million in Q3 2021.
  • Median Other Working Capital Changes over the past 5 years was -$47000.0 (2021), compared with a mean of -$153000.0.
  • Peak annual rise in Other Working Capital Changes hit 8208.57% in 2021, while the deepest fall reached 9533.33% in 2021.
  • NeuroPace's Other Working Capital Changes stood at -$47000.0 in 2021, then plummeted by 4761.7% to -$2.3 million in 2022, then surged by 147.7% to $1.1 million in 2023, then crashed by 103.94% to -$43000.0 in 2024, then soared by 1116.28% to $437000.0 in 2025.
  • The last three reported values for Other Working Capital Changes were $437000.0 (Q4 2025), -$1.5 million (Q3 2025), and $17000.0 (Q2 2025) per Business Quant data.